Guardion Health Sciences — Investor Presentation (January 2022)
17 slides from Guardion Health Sciences's investor presentation, Jan 10, 2022
Slide 1: Shape the future with momentum
Shape the future with momentum Guardion Health Sciences is’a company driven by innovation, working to improve quality of life through our clinical nutrition products. GUARDION HEALTH SCIENCES January 2022
Slide 2: Forward Looking Statement
j Forward Looking Statement This presentation of Guardion Health Sciences, Inc. (the “company,” “Guardion, or “our") includes "forward-looking statements" intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These statements rela
Slide 3: Corporate Overview
/ ‘ Corporate Overview 4 Guardion Health Sciences (Nasdaq: GHSI), is a clinical nutrition company that offers a portfolio of science-based, clinically-supported nutritional supplements and medical foods that support healthcare professionals, their patients, and consumers in achieving health goals Th
Slide 4: Synergy between Viactiv and Legacy Organization will Accelerate Growth
Synergy between Viactiv and Legacy Organization will Accelerate Growth Guardion ae ee of 2022 (pre-Viactiv) (and beyond) Clinical investment Strong brand Scientific advisors Consumer-loved products Doctor education Marketing expertise Extensive Distribution Channels GUARDION HEALTH SCIENCES
Slide 5: Highlights
Highlights Well-positioned to compete in the large and growing global nutrition market with differentiated and established product portfolio focused on bone, eye, and immune health Well defined value creation process focused on clinical evidence, product development and targeted marketing Science-ba
Slide 6: Nutrition Industry is Large and Growing
Nutrition Industry is Large and Growing Global Supplement and Medical Food Market “* Increasing awareness of the importance of nutrition “* Growing body of research demonstrating benefits of nutrition ** Increasing geriatric population with unique nutritional needs ** Specific to eye care, consumer
Slide 7: Well Defined Value Creation Process
Well Defined Value Creation Process Target customer base w/omni channel approach Outstanding products with impactful claims Strong Science & Clinical Evidence drive formulations Science- Customer i Product Targeted based a Needs : Development Marketing Formulation Understand the Create Execute clini
Slide 8: Leveraging Clinical Evidence
Leveraging Clinical Evidence Guardion is leveraging and creating a science / evidence-based foundation through clinical studies to support our nutrition product portfolio Investing in clinical research is fundamental to our model New placebo-controlled clinical study initiated on Glaucocetin in a ne
Slide 9: Health Sciences
HEALTH SCIENCES 4
Slide 10: Core Products Achieve Superior Consumer Experience and Distribution
7 Core Products Achieve Superior / Consumer Experience and Distribution Viactiv is a top brand in the calcium dietary supplement segment 5 j “» One of the fastest growing Calcium supplement brand, +8.6% YOY * Increasing market share “* Strong distribution in nearly every top retail chain Calcium + )
Slide 11: Viactiv, Lumega-Z and Glaucocetin products
Viacti Vv. Calcium+ IMMUNE Ee 90 *» Same base Calcium, plus high potency Vitamin D to boost immune system and calcium absorption * Zinc to support the immune system *» New Orange Cream flavor * Clinically proven to increase protective macular pigment * Clinically proven to improve contrast sensitivi
Slide 12: Leadership team and Board of Directors
r*AAF Bret Scholtes Susan Klein, ND Craig J. Sheehan Jeff Benjamin Liza Elder Chief Executive Officer Director of Chief Commercial Officer Chief Accounting Officer d Manager Board of Directors Medical Education Robert N. Weingarten David W. Evans, PhD Donald A. Gagliano, MD Mark Goldstone Michaela G
Slide 13: Financial Highlights
"Financial Highlights 4 *» Closed the Viactiv® acquisition on June 1, 2021 “ For 3Q21, total revenue was $3.15M; Viactiv contributed ~95% of GHSI total sales ** Cash and short-term investments at 9/30/21 were $10.6M and working capital was $12.9M; No debt on the balance sheet “* Management has been
Slide 14: Strategic Priorities — Driving Growth and Creating Value
’ Strategic Priorities — Driving Growth and Creating Value Brand Strategy — developing a strategy that best leverages Viactiv’s strong consumer awareness and acceptance Product Strategy — focusing product portfolio on differentiated formulations, product taste, compelling product formats, and compet
Slide 15: Potential Actions Over the Next Few Quarters
Potential Actions Over the Next Few Quarters * Improve communications channels * Complete and implement the results of business unit and product evaluation * New product development and product launches * Cost reduction activities and optimizing internal processes « Ramp up of commercial activities
Slide 16: Highlights
Highlights Well-positioned to compete in the large and growing global nutrition market with differentiated and established product portfolio focused on bone, ocular, and immune health Well defined value creation process focused on clinical evidence, product development and targeted marketing Science
Slide 17: Guardion Health Sciences is a clinical nutrition and diagnostics company
Guardion Health Sciences is a clinical nutrition and diagnostics GUARDION company that offers a portfolio of science-based, clinically- supported nutritional supplements, medical foods, and HEALTH SCIENCES diagnostic products that support healthcare professionals, their patients, and consumers in ac
Guardion Health Sciences — Investor Presentation (January 2022) on 6ix